{"id":"W2745845806","doi":"10.1093/rheumatology/kex301","title":"Secukinumab sustains improvement in signs and symptoms of psoriatic arthritis: 2 year results from the phase 3 FUTURE 2 study","year":2017,"lang":"en","type":"article","venue":"Lara D. Veeken","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":150,"is_retracted":false,"has_abstract":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Secukinumab; Medicine; Placebo; Dactylitis; Psoriatic arthritis; Tolerability; Adverse effect; Internal medicine; Psoriasis Area and Severity Index; Randomized controlled trial; Psoriasis; Enthesitis; Rheumatoid arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003784553,0.0009361615,0.001687061,0.0002367935,0.000467226,0.0008004,0.0005277749,0.001178811,0.00221058],"category_scores_gemma":[0.0011997,0.0003161037,0.001470774,0.0002215826,0.0005764749,0.00075681,0.0003404788,0.001919733,0.0006357981],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000470568,"about_ca_system_score_gemma":0.0008647018,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005278209,"about_ca_topic_score_gemma":0.000978619,"domain_scores_codex":[0.9993037,0.0003504099,0.00003722292,0.00005606504,0.0001062438,0.0001463823],"domain_scores_gemma":[0.998971,0.000176994,0.0002771338,0.0001143448,0.0001056168,0.0003549084],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6811404,0.08009236,0.02095223,0.000903868,0.002394695,0.0007325561,0.0006049449,0.001744009,0.04550317,0.0002743969,0.00673035,0.158927],"study_design_scores_gemma":[0.2494579,0.6733486,0.06337836,0.00008965671,0.0012302,0.0008175222,0.0001330547,0.001237746,0.005684758,0.0002660812,0.004298543,0.00005765819],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941462,0.002799777,0.0004523019,0.0003440466,0.00006291311,0.00058708,0.0007550729,0.00006186017,0.0007907122],"genre_scores_gemma":[0.9905397,0.002246169,0.001118941,0.0009621839,0.0001568142,0.001232464,0.002011413,0.00002973617,0.001702599],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003784553,"threshold_uncertainty_score":0.02001488,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01221630008356113,"score_gpt":0.2854264743297102,"score_spread":0.2732101742461491,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}